Valuation: Quest Laboratories Limited

Market Cap 171.08Cr 1.79Cr 1.57Cr 1.45Cr 1.34Cr 2.54Cr 2.58Cr 17Cr 6.79Cr 84Cr 6.73Cr 6.58Cr 291.01Cr P/E 2024 *
-
P/E 2025 12.4x
Enterprise Value 152Cr 1.59Cr 1.39Cr 1.28Cr 1.19Cr 2.26Cr 2.29Cr 15Cr 6.03Cr 75Cr 5.98Cr 5.85Cr 258.55Cr EV / Sales 2024 *
-
EV / Sales 2025 1.43x
Free-Float
99%
Yield 2024 *
-
Yield 2025 -
1 day+1.42%
1 week-5.07%
Current month-9.28%
1 month-10.10%
3 months-16.82%
6 months-12.32%
Current year-19.16%
1 week 87
Extreme 87
95.05
1 month 87
Extreme 87
122
Current year 87
Extreme 87
152.6
1 year 84
Extreme 84
152.6
3 years 75.15
Extreme 75.15
196.8
5 years 75.15
Extreme 75.15
196.8
10 years 75.15
Extreme 75.15
196.8
Manager TitleAgeSince
Chief Executive Officer 59 01/01/2024
Director of Finance/CFO 38 01/01/2024
Compliance Officer - 03/09/2025
Director TitleAgeSince
Director/Board Member 72 10/01/2024
Chairman 59 01/01/2024
Director/Board Member 30 05/03/2021
Change 5-day change 1-year change 3-year change Capi.($)
+1.42%-5.07%-1.93% - 1.5Cr
+0.09%+0.25%+54.65%+169.19% 1,08400Cr
-1.63%-1.50%+65.79%+62.70% 63TCr
-1.12%-4.27%+31.10%+84.44% 45TCr
+0.18%-1.76%+29.04%+26.51% 33TCr
-6.22%-8.14%+28.87%+32.09% 30TCr
-1.27%-2.91%+27.42%+46.39% 28TCr
-0.93%-3.57%-27.74%-40.38% 22TCr
-1.19%-2.81%+22.63%+66.30% 20TCr
-0.72%+2.72%+19.07%+81.19% 17TCr
Average -1.01%-2.02%+24.89%+58.71% 36.6TCr
Weighted average by Cap. -0.90%-1.18%+38.91%+84.80%

Financials

2024 2025
Net sales 83Cr 86.5L 75.67L 69.78L 64.56L 1.23Cr 1.25Cr 8.36Cr 3.28Cr 41Cr 3.25Cr 3.18Cr 140.44Cr 103.97Cr 1.09Cr 95.28L 87.87L 81.3L 1.54Cr 1.57Cr 11Cr 4.12Cr 51Cr 4.09Cr 4Cr 176.85Cr
Net income 10Cr 10.57L 9L 9L 8L 14.98L 15.23L 1.02Cr 40.05L 4.96Cr 39.7L 38.84L 17Cr 14Cr 14.21L 12.43L 11.47L 10.61L 20.14L 20.47L 1.37Cr 53.83L 6.66Cr 53.36L 52.2L 23Cr
Net Debt 4.94Cr 5L 5L 4L 4L 7L 7L 49.97L 19.59L 2.42Cr 19.42L 19L 8.4Cr -19Cr -19.99L -17.49L -16.13L -14.92L -28.32L -28.79L -1.93Cr -75.7L -9.37Cr -75.04L -73.42L -32Cr
Logo Quest Laboratories Limited
Quest Laboratories Limited is engaged in the business of manufacturing pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. It produces a variety of products, comprising ethical drugs, generic drugs, and over-the-counter drugs (OTC). These products are available in various forms, such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids. The tablets include Cetirizine Hydrochloride Tablet IP 10 mg, Zinc Sulphate Dispersible Tablet IP, Diclofenac Sodium Tablet BP, and others. It offers dry syrup and suspension, such as Ferrous Sulphate & Folic Acid Syrup, Albendazole Suspension IP, Zinc Oral Solution USP, Alpha Amilase & Pepsine, Sucralfate Suspension, and others. Its ointments include Silver Sulphadiazine Cream IP, Diclofenac Diethylamino IP Gel, and Povidone Iodine Ointment USP.
Employees
50
Date Price Change Volume
09/26/09 ₹89.00 +1.42% 2,400
08/26/08 ₹87.75 -0.28% 18,000
07/26/07 ₹88.00 -3.08% 19,200
06/26/06 ₹90.80 -4.37% 69,600
03/26/03 ₹94.95 +1.28% 50,400
  1. Stock Market
  2. Stocks
  3. QUESTLAB Stock